title: Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
authors.affiliation: Department of Surgery, University of Chicago, Illinois 60637.
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
authors.forename: T G
authors.initials: TG
authors.lastname: Heffron
authors.forename: J K
authors.initials: JK
authors.lastname: Stuart
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
authors.forename: F P
authors.initials: FP
authors.lastname: Stuart
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use*; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone